NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.
The NICE has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England.
Endometriosis occurs when cells similar to those in the lining of the womb grow in other parts of the body, such as the pelvis, bladder and bowel.